Skip to main content

2 Result(s)

within Thomas Decaens Remove this filter Biomedicine, general Remove this filter Epidemiology Remove this filter

and

  1. Article

    Open Access

    Correction: Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression

    Thomas Decaens, Carlo Barone, Eric Assenat, Martin Wermke… in British Journal of Cancer (2021)

    Download PDF (222 KB) View Article

  2. Article

    Open Access

    Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression

    This Phase 1b/2 study evaluated tepotinib, a highly selective MET inhibitor, in US/European patients with sorafenib pretreated advanced hepatocellular carcinoma (aHCC) with MET overexpression.

    Thomas Decaens, Carlo Barone, Eric Assenat, Martin Wermke… in British Journal of Cancer (2021)

    Download PDF (465 KB) View Article